ENTITY
Yichang HEC Changjiang Pharma

Yichang HEC Changjiang Pharma (1558 HK)

122
Analysis
Health Care • Hong Kong
YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs. The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.
more
bullish•Topcon Corp
•03 Aug 2025 06:15

(Mostly) Asia-Pac M&A: Topcon, Joy City, Hogy Medical, Nihon Chouzai, Piedmont Lithium, Pacific Ind.

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
523 Views
Share
bullish•Topcon Corp
•01 Aug 2025 06:15

(Mostly) Asia M&A, July 2025 Wrap: Pacific Industrial, Johns Lyon, TalkMed, DD Group, Hanil Cement

For the month of July, 6 new deals were discussed on Smartkarma with an overall deal size of just ~US$4bn. The average premium for the new deals...

Logo
433 Views
Share
bullish•MAC Copper
•31 Jul 2025 11:53

MAC Copper (MAC AU/MTAL US): 29th August Vote On Harmony's Offer

Both legs have the same gross/annual. spreads of 1.5%/7.9%, assuming early Oct payment. There will be nominal costs to be netted off the CDI...

Logo
369 Views
Share
bullish•PointsBet Holdings
•30 Jul 2025 11:59

PointsBet (PBH AU): Either Betr Pulls A Rabbit Out Of The Hat, Or Walks

I can see Mixi waiving the acceptance condition and declaring term unconditional. Trading at terms. If in, sell here. If not in, avoid unless...

Logo
310 Views
Share
•28 Jul 2025 10:28

Ainsworth Game Technology (AGI AU): 29th August Vote On Novomatic's "Low-Balled Offer"

I think this gets up. And that's a chunky franked dividend with respect to the Offer price. For those who can take advantage. Key shareholders have...

Logo
450 Views
Share
x